Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
We welcome the publication of the government's Life Sciences Sector Plan, which sets out how NICE will ensure patients get faster, fairer access to transformative new medicines and life-changing healthtech, while supporting a thriving life sciences industry in the UK.
NICE approves ribociclib combination therapy to help prevent cancer returning in early-stage disease.
The technologies could help healthcare professionals spot hidden spinal fractures in patients undergoing routine CT scans.
Some people with cystic fibrosis are set to benefit from a new once-daily triple therapy treatment, following NICE's recommendation of Alyftrek in final draft guidance published today.
Best practice resources for practitioners and commissioners.
Helping you define, improve and measure quality in health, public health and social care.
Resources and recommendations for adult and children’s social care, with example scenarios to help put them into practice.
Explore ways to plan, save money and make decisions on the best ways to use resources.
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
The British National Formulary (BNF) provides information about the selection, prescribing, dispensing and administration of drugs.
Summaries of evidence and advice on common health topics (CKS)
With over 370 topics to choose from, clinical knowledge summaries (CKS) can provide quick answers to clinical questions.
Our patient decision aids (PDAs) include treatment options available, likely outcomes, benefits, harms and uncertainties.
Our NICE Advice service will guide you there.
Get reliable scientific advice and NHS insights, direct from NICE. We support companies seeking nationwide adoption of the best treatments and care.
